昨夜星辰
‘풋살로 한·중 우애 쌓는다’…경기대 수원캠퍼스 K-PARK서 한·중 청소년 풋살 캠프 개최_我的网站
A |
China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday.
The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness.
By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source.
In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report.
Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations.
"Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang.
The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added.
Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report.
Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology.
Global Times
。 경기대 수원캠퍼스 K 파크 등에서 열린 ‘2026 한·중 청소년 풋살 문화교류 캠프’에 참가한 선수들이 기념 사진을 찍고 있다. 경기대 제공경기대는 수원캠퍼스 K-파크 등지에서 ‘2026 한·중 청소년 풋살 문화교류 캠프’를 개최했다고 26일 밝혔다.지난 21~24일 열린 캠프에는 중국 측 106명, 한국 측 572명 등 총 700여 명이 참여했다. 행사는 한국청소년단체협의회와 (사)한국국제문화교류원, 중국국제청년교류중심, 중국 연태시대외우호협회 등 한·중 기관이 공동 주최했으며, 경기대 등이 후원그룹으로 참여했다.올해 한·중 수교 34주년을 맞아 처음 열린 캠프 개회식은 지난 22일 경기대 수원캠퍼스 K-파크에서 열렸다. 학교법인 경기학원 손율 이사장은 개회식 축사에서 “스포츠와 문화교류를 통해 한·중 청소년들이 우정을 쌓아갔으면 한다”고 밝혔다.23일 열린 시상식에는 김현수 경기대 총장 직무대행이 참석했다. 경기대 관계자는 “이번 캠프를 통해 수원캠퍼스의 우수한 체육시설과 교육환경을 활용한 국제교류 및 청소년 활동을 앞으로도 적극 지원하겠다”고 말했다.。
Current article:http://www.lichuorenrenyitankanmeimu.cfd/7rwa/20260826/9263.ppt
Published on:10:56:24
